MILLIMAN DNA Trademark

Trademark Overview

On Saturday, March 13, 2021, a trademark application was filed for MILLIMAN DNA with the United States Patent and Trademark Office. The USPTO has given the MILLIMAN DNA trademark a serial number of 90577470. The federal status of this trademark filing is REGISTERED as of Tuesday, February 21, 2023. This trademark is owned by Milliman, Inc.. The MILLIMAN DNA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing temporary use of an interactive and dynamic web-based software application for developing estimates, intended to help primary and secondary insurance payers better understand the potential utilization and costs associated with cell and gene therapies that are in Phase 2 or later clinical development
milliman dna

General Information

Serial Number90577470
Word MarkMILLIMAN DNA
Filing DateSaturday, March 13, 2021
Status700 - REGISTERED
Status DateTuesday, February 21, 2023
Registration Number6987160
Registration DateTuesday, February 21, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2022

Trademark Statements

Section 2(f) Limitation Statementas to "MILLIMAN"
Disclaimer with Predetermined Text"DNA"
Goods and ServicesProviding temporary use of an interactive and dynamic web-based software application for developing estimates, intended to help primary and secondary insurance payers better understand the potential utilization and costs associated with cell and gene therapies that are in Phase 2 or later clinical development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 14, 2021
Primary Code042
First Use Anywhere DateSunday, January 31, 2021
First Use In Commerce DateSunday, January 31, 2021

Trademark Owner History

Party NameMilliman, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98101
Party NameMilliman, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98101
Party NameMilliman, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98101

Trademark Events

Event DateEvent Description
Tuesday, February 21, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 21, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, January 17, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sunday, January 15, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 22, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, December 2, 2022USE AMENDMENT FILED
Thursday, December 22, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 2, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 4, 2022PUBLISHED FOR OPPOSITION
Wednesday, September 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 29, 2022EXAMINER'S AMENDMENT ENTERED
Monday, August 29, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 29, 2022EXAMINERS AMENDMENT E-MAILED
Monday, August 29, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, July 18, 2022ASSIGNED TO EXAMINER
Monday, June 27, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 27, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 27, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 1, 2022NON-FINAL ACTION E-MAILED
Tuesday, March 1, 2022NON-FINAL ACTION WRITTEN
Thursday, January 13, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 13, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 13, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 17, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 17, 2021NON-FINAL ACTION E-MAILED
Friday, September 17, 2021NON-FINAL ACTION WRITTEN
Thursday, September 9, 2021ASSIGNED TO EXAMINER
Monday, June 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 17, 2021NEW APPLICATION ENTERED

Related Keywords

milliman costs associated utilization potential better understand cell gene clinical development